I've posted about my father here before - you can check my post history for my older posts.
To keep it brief: 60 years old, diagnosed with metastatic prostate cancer in June of last year (at 59). Doctor started with hormonal treatment while waiting for him to regain some strength, added Abiraterone (Zytiga) and Docetaxel chemotherapy as soon as his body could handle it effectively starting triplet therapy. After 6 cycles that ended around 3 weeks ago, we got the worst possible news today: he did not respond that well to the treatment (the doctor is calling it a "mixed response" and is saying that he's not anticipating a response with more cycles or other types of chemotherapy). He's looking at other clinical trials, or possibly Lu-177 (apparently, there is a global shortage of this and it is not readily available here in Canada).
Anyone else familiar with this situation?
It all went downhill so fast...